mark roberge

T2 · manager / operator

Mark Roberge scaled HubSpot from $0 to $100M+ ARR as CRO, led its IPO, then joined Kleiner Perkins as a partner while teaching a popular sales course at HBS. He founded Stage 2 Capital (a $100M fund backed by 1,000+ CROs/CMOs) and recently launched Roadrunner, an AI-native CPQ startup backed by Founders Fund. Author of 'The Science of Scaling.'

10 calls·10 names·50% bull·last heard 20 days ago·Kleiner Perkins
track record

no scored calls yet — needs a stated position or a categorical verdict, with a matured window vs SPY

top calls

highest conviction · one per company
1sthigh conviction
$STAGE-2-CAPITALStage 2 Capitalposition

Stage 2 Capital closes $100M Fund IV with 1,000+ CRO/CMO LPs for go-to-market expertise

Stage 2 Capital's LP base of 1,000+ sales and marketing executives creates a unique go-to-market value-add platform for portfolio companies across any B2B sector, differentiating the fund in pre-seed/seed investing.

2ndhigh conviction
$ROADRUNNERRoadrunnerposition

Roadrunner targets mission-critical CPQ with AI-native architecture and accountability moat

CPQ is a misunderstood, mission-critical category where incumbents have rigid data models that can't handle modern pricing; AI enables flexible reasoning over price/rule books, and the vendor assumes liability for quote accuracy creating a 'CYA' accountability moat that drives enterprise trust and adoption.

3rdhigh conviction
$FOUNDERS-FUNDFounders Fundposition

Founders Fund leads Roadrunner Series A for long-term partnership over valuation optimization

Founders Fund's persistence and track record (incubating Anduril, early in Rippling/Figma/Slack) signaled deep understanding of messy early-stage scaling, making them the right partner despite Mark's initial instinct to delay fundraising until more contracts closed.

10 total
$STAGE-2-CAPITAL
Stage 2 Capital
HIGHmark roberge·Kleiner Perkins·20 days ago· position
Stage 2 Capital closes $100M Fund IV with 1,000+ CRO/CMO LPs for go-to-market expertise
Stage 2 Capital's LP base of 1,000+ sales and marketing executives creates a unique go-to-market value-add platform for portfolio companies across any B2B sector, differentiating the fund in pre-seed/seed investing.
"we just uh actually to today by midnight, we closed our fourth fund at Stage 2 Capital. Congrats. We're over a thousand CRO and CMOs as LPs now. So, we can cover almost any B2B br…"
81:40
$GLEAN
Glean
MEDmark roberge·Kleiner Perkins·20 days ago· position
Glean proved enterprise search timing works but now faces flanking from foundation models
Glean succeeded in a 'dead' category because timing, technology, and founder aligned, catalyzing competitor interest from Anthropic, Perplexity, OpenAI, and Microsoft; the moat now depends on distribution, brand trust, and enterprise sales execution since all competitors have access to the same frontier models.
"I remember this with Glean. Everyone was like enterprise search. I don't get it cuz there probably was a cloud first version in 2010... And eventually because of their own success…"
11:40
$ANTHROPIC
Anthropic
MEDmark roberge·Kleiner Perkins·20 days ago
Foundation models enable internal build threat but vertical apps retain workflow and compliance moats
Claude and similar models lower the barrier for enterprises to build internal tools like CPQ, but the complexity of data models, pricing engines, multi-stakeholder workflows, integrations, legal compliance, and load testing creates a massive implementation gap that favors specialized vendors over DIY approaches.
"Let's just imagine we have those 17 IT people that can go do this with Claude... First we have to assume that Claude, not them, can build the data model from scratch... Then we ha…"
27:30
$RIPPLING
Rippling
MEDmark roberge·Kleiner Perkins·20 days ago
Rippling referenced as unique compound startup at scale with no historical precedent
Rippling's compound product strategy at scale has no historical precedent, forcing Parker Conrad to invent the playbook in real time — a pattern Mark sees across generational companies like Glean and Microsoft under Satya.
"And like that's not a knock on Arvin. He's like the most competent founder you could find. But like there has never been a company like this in this moment in time. And so like yo…"
12:10
$HARVEY
Harvey
HIGHmark roberge·Kleiner Perkins·20 days ago
Harvey grouped with Sierra as AI app with questionable unit economics behind PLG growth
Harvey's rapid growth relies on PLG distribution to legal professionals using experimentation budgets rather than production deployments, creating revenue that may not sustain when budgets tighten; lacks go-to-market fit with capped burn ratios and realistic unit economics.
"if you're like an AI native company, you see companies like Sierra and Harvey and blah blah blah all growing this fast and you're like, 'All right, I'll just like hedge and I'll p…"
68:40
$ANDURIL
Anduril
MEDmark roberge·Kleiner Perkins·20 days ago
Anduril cited as outlier outcome from Founders Fund incubation at $60B valuation
Anduril's trajectory from incubation to $60B valuation exemplifies the outlier outcomes possible when exceptional founders pair with patient, long-term capital that understands scaling messiness.
"Trey incubated Ando, they're raising at 60 billion. That's like public, right?"
78:40
$ROADRUNNER
Roadrunner
HIGHmark roberge·Kleiner Perkins·20 days ago· position
Roadrunner targets mission-critical CPQ with AI-native architecture and accountability moat
CPQ is a misunderstood, mission-critical category where incumbents have rigid data models that can't handle modern pricing; AI enables flexible reasoning over price/rule books, and the vendor assumes liability for quote accuracy creating a 'CYA' accountability moat that drives enterprise trust and adoption.
"CPQ is unique because it touches it, deals desk, revops, sales, finance minimally just to get from a quote to a deal approved to the customer... if it uses the lowest common denom…"
6:09
$FOUNDERS-FUND
Founders Fund
HIGHmark roberge·Kleiner Perkins·20 days ago· position
Founders Fund leads Roadrunner Series A for long-term partnership over valuation optimization
Founders Fund's persistence and track record (incubating Anduril, early in Rippling/Figma/Slack) signaled deep understanding of messy early-stage scaling, making them the right partner despite Mark's initial instinct to delay fundraising until more contracts closed.
"FF stayed persistent and they were like, 'We want to do this.' Like, 'We just want to do this.' And they were the right partner for us... Mimoon and Trey, right? Like, okay, Trey…"
72:40
$SIERRA
Sierra
HIGHmark roberge·Kleiner Perkins·20 days ago
Sierra and Harvey show 'groupon-like' growth with weak unit economics and PLG distribution risk
Fast-growing AI application companies like Sierra and Harvey are distributing through PLG motions inherited from Dropbox 2010 that attract SMB experimentation budgets, not production budgets, resulting in contracted ARR that masks poor retention, unit economics, and circular revenue dynamics.
"having looked under the hood at some of those companies it's not all clean living like if we just attach ourselves to product market fit and go to market fit if they looked at the…"
68:40
$CRM
···
Salesforce
MEDmark roberge·Kleiner Perkins·20 days ago
Salesforce unlikely to cannibalize CPQ revenue aggressively enough to stop AI-native entrants
Incumbents like Salesforce face innovator's dilemma in CPQ: cannibalizing their own legacy revenue to adopt AI-native architecture is organizationally difficult, creating a window for startups to capture the upmarket enterprise segment before incumbents respond.
"And if the answer is like, okay, well, is Salesforce going to move faster to cannibalize their own business before we get to distribution? Like, are they going to get to innovatio…"
22:30